These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 32483520)
1. Preclinical evaluation of cationic DOTA-triarginine-lipid conjugates for theranostic liquid brachytherapy. Wang W; Fliedner FP; Hansen AE; Eliasen R; Melander F; Kjaer A; Andresen TL; Jensen AI; Henriksen JR Nanotheranostics; 2020; 4(3):142-155. PubMed ID: 32483520 [TBL] [Abstract][Full Text] [Related]
2. Remote-loading of liposomes with manganese-52 and in vivo evaluation of the stabilities of Jensen AI; Severin GW; Hansen AE; Fliedner FP; Eliasen R; Parhamifar L; Kjær A; Andresen TL; Henriksen JR J Control Release; 2018 Jan; 269():100-109. PubMed ID: 29122662 [TBL] [Abstract][Full Text] [Related]
3. A positron emission tomography image-guidable unimolecular micelle nanoplatform for cancer theranostic applications. Yang J; Lu W; Xiao J; Zong Q; Xu H; Yin Y; Hong H; Xu W Acta Biomater; 2018 Oct; 79():306-316. PubMed ID: 30172067 [TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography based analysis of long-circulating cross-linked triblock polymeric micelles in a U87MG mouse xenograft model and comparison of DOTA and CB-TE2A as chelators of copper-64. Jensen AI; Binderup T; Kumar EK P; Kjær A; Rasmussen PH; Andresen TL Biomacromolecules; 2014 May; 15(5):1625-33. PubMed ID: 24645913 [TBL] [Abstract][Full Text] [Related]
5. Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical. Lopez-Rodriguez V; Gaspar-Carcamo RE; Pedraza-Lopez M; Rojas-Calderon EL; Arteaga de Murphy C; Ferro-Flores G; Avila-Rodriguez MA Nucl Med Biol; 2015 Feb; 42(2):109-14. PubMed ID: 25316595 [TBL] [Abstract][Full Text] [Related]
6. Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer. Benešová M; Schäfer M; Bauder-Wüst U; Afshar-Oromieh A; Kratochwil C; Mier W; Haberkorn U; Kopka K; Eder M J Nucl Med; 2015 Jun; 56(6):914-20. PubMed ID: 25883127 [TBL] [Abstract][Full Text] [Related]
8. Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer. Deshayes E; Ladjohounlou R; Le Fur P; Pichard A; Lozza C; Boudousq V; Sevestre S; Jarlier M; Kashani R; Koch J; Sosabowski J; Foster J; Chouin N; Bruchertseifer F; Morgenstern A; Kotzki PO; Navarro-Teulon I; Pouget JP J Nucl Med; 2018 Aug; 59(8):1234-1242. PubMed ID: 29674421 [TBL] [Abstract][Full Text] [Related]
9. In vivo evaluation of PEGylated ⁶⁴Cu-liposomes with theranostic and radiotherapeutic potential using micro PET/CT. Petersen AL; Henriksen JR; Binderup T; Elema DR; Rasmussen PH; Hag AM; Kjær A; Andresen TL Eur J Nucl Med Mol Imaging; 2016 May; 43(5):941-952. PubMed ID: 26646780 [TBL] [Abstract][Full Text] [Related]
10. Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes. Carlos Dos Santos J; Beijer B; Bauder-Wüst U; Schäfer M; Leotta K; Eder M; Benešová M; Kleist C; Giesel F; Kratochwil C; Kopka K; Haberkorn U; Mier W J Nucl Med; 2020 Jan; 61(1):70-79. PubMed ID: 31541034 [TBL] [Abstract][Full Text] [Related]
11. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors. Oxboel J; Brandt-Larsen M; Schjoeth-Eskesen C; Myschetzky R; El-Ali HH; Madsen J; Kjaer A Nucl Med Biol; 2014 Mar; 41(3):259-67. PubMed ID: 24417983 [TBL] [Abstract][Full Text] [Related]
12. Development of a Theranostic Convergence Bioradiopharmaceutical for Immuno-PET Based Radioimmunotherapy of L1CAM in Cholangiocarcinoma Model. Song IH; Jeong MS; Hong HJ; Shin JI; Park YS; Woo SK; Moon BS; Kim KI; Lee YJ; Kang JH; Lee TS Clin Cancer Res; 2019 Oct; 25(20):6148-6159. PubMed ID: 31337646 [TBL] [Abstract][Full Text] [Related]
13. [ Lau J; Kwon D; Rousseau E; Zhang Z; Zeisler J; Uribe CF; Kuo HT; Zhang C; Lin KS; Bénard F Mol Pharm; 2019 Nov; 16(11):4688-4695. PubMed ID: 31545614 [TBL] [Abstract][Full Text] [Related]
14. New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts. Persson M; Rasmussen P; Madsen J; Ploug M; Kjaer A Nucl Med Biol; 2012 Oct; 39(7):962-9. PubMed ID: 22739362 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of copper-64 labeled AmBaSar conjugated cyclic RGD peptide for improved microPET imaging of integrin alphavbeta3 expression. Cai H; Li Z; Huang CW; Shahinian AH; Wang H; Park R; Conti PS Bioconjug Chem; 2010 Aug; 21(8):1417-24. PubMed ID: 20666401 [TBL] [Abstract][Full Text] [Related]
16. Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model. Iguchi Y; Michiue H; Kitamatsu M; Hayashi Y; Takenaka F; Nishiki T; Matsui H Biomaterials; 2015 Jul; 56():10-7. PubMed ID: 25934274 [TBL] [Abstract][Full Text] [Related]
19. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression. Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975 [TBL] [Abstract][Full Text] [Related]
20. Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent β--emitters: in vitro and in vivo study of a 44Sc-DOTA-folate conjugate. Müller C; Bunka M; Reber J; Fischer C; Zhernosekov K; Türler A; Schibli R J Nucl Med; 2013 Dec; 54(12):2168-74. PubMed ID: 24198390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]